LobbyingSpecialty Tobacco Council lobbying by quarter
Specialty Tobacco Council's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Tobacco and Trade (Domestic & Foreign).
Specialty Tobacco Council
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Tobacco$0 · 15 reports
- Trade$0 · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)15 reports
- Health & Human Services, Dept of (HHS)15 reports
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseSpecialty Tobacco Council | $0 | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/21for Q2 | In-house | Under $5,000 |
| 04/15for Q1 | In-house | Under $5,000 |
| 02/11for Q4 2025 | In-house | Under $5,000 |
| 25/10/13for Q3 2025 | In-house | Under $5,000 |
| 25/07/22for Q2 2025 | In-house | Under $5,000 |
| 25/06/03for Q1 2025 | In-house | Under $5,000 |
| 25/06/03for Q1 2025 | In-house | Under $5,000 |
| 25/03/10for Q4 2024 | In-house | Under $5,000 |
| 24/12/02for Q3 2024 | In-house | Under $5,000 |
| 24/07/25for Q2 2024 | In-house | Under $5,000 |
| 24/04/20for Q1 2024 | In-house | Under $5,000 |
| 24/02/06for Q4 2023 | In-house | Under $5,000 |
| 23/10/20for Q3 2023 | In-house | Under $5,000 |
| 23/07/30for Q2 2023 | In-house | Under $5,000 |
| 23/04/16for Q1 2023 | In-house | Under $5,000 |
| 23/02/07for Q4 2022 | In-house | Under $5,000 |